Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300406
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,201
Award facts
- Contract value 100% obligated
- $3,201.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
About this award
Lonza Walkersville, Inc., a foreign-owned manufacturer of biological materials and laboratory equipment headquartered in Walkersville, Maryland, received a Blanket Purchase Agreement (BPA) call award valued at $3,201.24 from the U.S. government's Office of the Director on March 27, 2014. This Firm Fixed Price contract, which was not set aside for small business or other special designations, is classified under Drugs and Biologicals and has an ultimate completion date of December 31, 2014. The award represents a task order call against Lonza Walkersville's existing BPA with the Health and Human Services (HHS) Office of Logistics and Acquisition Operations, a $10 million umbrella agreement valid through December 31, 2025 that enables streamlined procurement of biological materials, blood products, media products, laboratory supplies, and medical and scientific equipment.
As a subsidiary of the global Lonza Group and a registered SAM.gov vendor since 2002, Lonza Walkersville has established itself as a critical supplier to federal research institutions, particularly the National Institutes of Health (NIH) and its various institutes including the National Cancer Institute and National Institute of Allergy and Infectious Diseases. The company's contract portfolio reflects specialization in high-precision biological research products such as cell culture media, specialized cell lines, transfection devices, and advanced scientific instrumentation that support critical research in cancer studies, infectious diseases, regenerative medicine, and cellular engineering across multiple federal agencies.
Quick answers
Who was awarded contract HHSN26300406?
HHSN26300406 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on March 27, 2014.
How much is contract HHSN26300406 worth?
The government has obligated $3,201 on HHSN26300406.
Is contract HHSN26300406 an order under another contract?
Yes. HHSN26300406 is a BPA call under HHSN263199900049886B, a blanket purchase agreement.
Was contract HHSN26300406 competed?
The extent of competition for HHSN26300406 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award